- Home
- OCEAW vs FISI Comparison
OCEAW vs FISI Comparison
Compare OCEAW & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- FISI
- Stock Information
- Founded
- OCEAW N/A
- FISI 1817
- Country
- OCEAW United States
- FISI United States
- Employees
- OCEAW 7
- FISI N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- FISI Major Banks
- Sector
- OCEAW Health Care
- FISI Finance
- Exchange
- OCEAW Nasdaq
- FISI Nasdaq
- Market Cap
- OCEAW N/A
- FISI N/A
- IPO Year
- OCEAW 2021
- FISI 1999
- Fundamental
- Price
- OCEAW $0.02
- FISI $22.35
- Analyst Decision
- OCEAW
- FISI Buy
- Analyst Count
- OCEAW 0
- FISI 3
- Target Price
- OCEAW N/A
- FISI $33.00
- AVG Volume (30 Days)
- OCEAW N/A
- FISI 249.0K
- Earning Date
- OCEAW N/A
- FISI 04-28-2025
- Dividend Yield
- OCEAW N/A
- FISI 5.55%
- EPS Growth
- OCEAW N/A
- FISI N/A
- EPS
- OCEAW N/A
- FISI N/A
- Revenue
- OCEAW N/A
- FISI $110,758,000.00
- Revenue This Year
- OCEAW N/A
- FISI $84.52
- Revenue Next Year
- OCEAW N/A
- FISI $6.74
- P/E Ratio
- OCEAW N/A
- FISI N/A
- Revenue Growth
- OCEAW N/A
- FISI N/A
- 52 Week Low
- OCEAW N/A
- FISI $16.29
- 52 Week High
- OCEAW N/A
- FISI $29.79
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- FISI 36.70
- Support Level
- OCEAW N/A
- FISI $20.97
- Resistance Level
- OCEAW N/A
- FISI $22.58
- Average True Range (ATR)
- OCEAW 0.00
- FISI 1.17
- MACD
- OCEAW 0.00
- FISI -0.00
- Stochastic Oscillator
- OCEAW 0.00
- FISI 31.51
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.